Consistently, in vivo experiments showed a decrease in melanoma growth after NRAS depletion, associated with the suppression of Ras/RAF/MEK/ERK and PI3K/Akt pathways (Liu S. et al., 2017). The gene discussed is AKT1; the disease is melanoma.